West Pharmaceutical Services Inc. closed $84.74 short of its 52-week high ($413.70), which the company reached on February ...
West Pharmaceutical Services Inc. closed $81.97 below its 52-week high ($413.70), which the company reached on February 7th.
Nordea Investment Management AB increased its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) ...
Stock analysts at Citigroup started coverage on shares of West Pharmaceutical Services (NYSE:WST – Get Free Report) in a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
West Pharmaceutical Services (WST) has received a new Buy rating, initiated by Citi analyst, Patrick B Donnelly.Stay Ahead of the ...
West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and sustained strength in research and development (R&D). However, foreign ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.